Bay Area Ending Disparities in CKD Stakeholder Summit

About the Initiative

Approximately 4,400,000 adults in California are affected by CKD, but fewer than 500,000 are aware of their condition. As part of a national NKF Collective Impact strategy, Bay Area stakeholders are implementing a roadmap to drive a cultural shift in primary care toward increasing the early diagnosis and management of CKD.

Collective Impact Process

Using a multi-phase stakeholder engagement process, NKF will create the conditions for Collective Impactinfluential champions, adequate financial resources, and a sense of urgency for change1to drive change in the Bay Area.

Learning and Action Workgroups

Through a series of facilitated discussions, leaders in health care and public health will identify barriers and solutions to improve CKD awareness, detection, and management in the Bay Area, and especially tools and strategies that can be implemented within stakeholders' own institutions. Four workgroups will convene covering the following topics:

Clinical Considerations for CKD in Primary Care

  • Goal: Discuss strategies and approaches that can be employed to improve CKD recognition and care in primary care settings.
  • Background: A large, national study illustrated that less than 12% of people with CKD were diagnosed in primary care.This included as many as 40% of people whose kidneys required specialty care. With the advent of new therapies demonstrated to slow or stop the progression of CKD, there is a very real opportunity to improve quality of care for people with CKD across the entire disease spectrum.

The meetings of this workgroup are to be determined.

Community-Centered Engagement and Solutions

  • Goal: Develop strategies to advance CKD awareness through community engagement and to ensure that health care providers are aware of the community resources available to delay CKD progression. 
  • Background: In the US today, only 10% of people with laboratory evidence of CKD know that they have kidney disease.Improved patient awareness, engagement, and self-management are vital to successfully slowing CKD progression. As diabetes and hypertension play significant roles in the development of CKD, working with community organizations that support people with chronic disease can be an important step toward raising public awareness of CKD among those at risk.

​The meetings of this workgroup are to be determined.

Policy, Payment, and Quality Measurement

  • Goal: Develop a strategy to streamline CKD testing in primary care from a policy and payment perspective.
  • Background: In July 2020, the NCQA released the Kidney Health Evaluation for Adults with Diabetes HEDIS measure (KHE).This measure assesses the percentage of people with diabetes that receive both tests for CKD during the course of a year. 2021 reporting year data shows average measure satisfaction of only 33-45% across payer types.2

​The meetings of this workgroup are to be determined.

Wellness and Prevention

  • Goal: Develop a strategy to incorporate CKD testing and diagnosis into wellness and prevention practices within employer/ commercial health plans, and the broader community.
  • Background: To date, almost 90% of people living with CKD remain undiagnosed and the majority will not receive guideline recommended annual testing.This workgroup will craft and propose the strategies that can be implemented to ensure that CKD testing and diagnosis are included as part of population health approaches (e.g., corporate wellness programs, disease prevention activities, payer-led prevention strategies) that are available in the Bay Area.

​The meetings of this workgroup are to be determined.

Roadmap

Check back soon for a summary of our roadmap strategies, expected March 2024.

Leadership Summit

Join us March 2024 for a virtual summit where we will convene and discuss solutions compiled from our four workgroups. Registration to come.

Learn More and Join the Collective Impact Effort

Nina Sherpa-Pine (she/her/hers/any pronouns used respectfully), Director of Community Impact and Health Partnerships: nina.sherpapine@kidney.org

References

  1. Hanley Brown, F. Kania, J. and Kramer, M. Channeling Change: Making Collective Impact Work. Stanford Social Innovation Review. 2012. https://doi.org/10.48558/2T4M-ZR69  
  2. Szczech, Lynda A., et al. “Primary Care Detection of Chronic Kidney Disease in Adults with Type-2 Diabetes: The ADD-CKD Study (Awareness, Detection and Drug Therapy in Type 2 Diabetes and Chronic Kidney Disease).” Public Library of Science, 26 Nov. 2014. https://doi.org/10.1371/journal.pone.0110535
  3. “Chronic Kidney Disease (CKD) Surveillance System: Awareness.” Centers for Disease Control and Preventionhttps://nccd.cdc.gov/ckd/detail.aspx?QNum=Q97#refreshPosition
  4. Brock, Matt. “Kidney Health: A New HEDIS Measure.” NCQA Blog, 16 Jul. 2020. https://blog.ncqa.org/kidneyhealth/
  5. “Chronic Kidney Disease in the United States, 2021.” Centers for Disease Control and Prevention, 4 Mar. 2021. https://www.cdc.gov/kidneydisease/pdf/Chronic-Kidney-Disease-in-the-US-2021-h.pdf